To view videos with matches, highlights & goals, previews, iconic moments and more, visit OneFootball.

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

The latest news and analysis of the global railway industry from the world's leading international publication.

Our writer reveals what he thinks is the most exciting from the four investments he made in his Stocks and Shares ISA last ...

Enquanto o presidente americano Donald Trump e seus assessores começam a avaliar substitutos para o presidente do Federal ...

There is always a challenging moment in every investor’s favorite stock and portfolio, especially when said businesses are ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Backed by tech billionaires, the crypto-focused digital startup bank's timely application reflects the current administration ...

The application follows on the heels of Circle and Wise, as crypto and payment companies seek crypto custody approval and ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

The Orissa High Court held that the reconstituted GSTAT (Central Goods and Services Tax Appellate Tribunal) selection ...